A Review of Quality of Life in Alzheimer’s Disease: Parts 1 and 2: Issues in Assessing Disease Impact and Drug Effects

Author： Greer M.   Monteban H.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.15, Iss.6, 1999-06, pp. : 641-644

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Review of Quality of Life in Alzheimer's Disease: Parts 1 and 2: Issues in Assessing Disease Impact and Drug Effects

By McKenna S.P.   Doward L.C.  

PharmacoEconomics, Vol. 16, Iss. 4, 1999-10 ,pp. : 417-419

Adis International

Access to resources Recommend Favorite

A Review of Quality of Life in Alzheimer's Disease: Part 2: Issues in Assessing Drug Effects

By Salek S.S.  

PharmacoEconomics, Vol. 14, Iss. 6, 1998-12 ,pp. : 613-627

Adis International

Access to resources Recommend Favorite

A Review of Quality of Life in Alzheimer's Disease: Part 1: Issues in Assessing Disease Impact

By Walker M.D.  

PharmacoEconomics, Vol. 14, Iss. 5, 1998-11 ,pp. : 499-530

Adis International

Access to resources Recommend Favorite

The presenilins as potential drug targets in Alzheimer’s disease

By Cupers P.   Annaert W.G.   Strooper B.D.  

Expert Opinion on Therapeutic Targets, Vol. 3, Iss. 3, 1999-09 ,pp. : 413-422

Informa Healthcare

Access to resources Recommend Favorite

New concepts in the drug therapy of Alzheimer’s disease

By Farlow Martin R   Hake Ann Marie  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 12, 2001-12 ,pp. : 1975-1983

Informa Healthcare

Access to resources Recommend Favorite